Bionpharma Inc. recalls
Every recall we track for Bionpharma Inc. — 4 in all, from 2019–2026 — plus the complaints and injury reports the public filed about them.
Recalls per year, by danger level
4 recalls since 2017.
All FDA recall records for Bionpharma Inc. since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 1 | 1 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 1 | 0 | 1 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 (to date) | 0 | 0 | 0 | 2 | 2 |
Most common reasons for Bionpharma Inc. recalls
What to do if you have a recalled Bionpharma Inc. product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All Bionpharma Inc. recalls
4 shown- UnratedDrug
Bionpharma Inc. recalls Doxylamine Succinate and Pyridoxine HCl Delayed-Release tablets 10 mg/10 mg, 100-count bottle, Rx Only, MADE IN INDIA,
Bionpharma recalls 100-count Doxylamine Succinate and Pyridoxine HCl tablets (Rx only) made in India due to foreign tablets present. Consumers should contact the company for details.
BionpharmaAug 7, 2026 - UnratedDrug
Bionpharma Inc. recalls Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by: Bionpharma Inc.,
Bionpharma recalls 500mg Divalproex Sodium Delayed-Release Tablets due to foreign tablets present. Affected lots may cause injury if taken.
BionpharmaJun 26, 2026 - Lower riskDrug
Bionpharma Inc. recalls Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ
Bionpharma recalls Atovaquone Oral Suspension (750 mg/5 mL) due to Cohnella bacterial contamination. This prescription medication poses a microbial risk. Consumers should contact the manufacturer for details.
BionpharmaSep 17, 2024 - UnratedDrug
Bionpharma Inc. recalls Clobazam Oral Suspension, 2.5 mg/mL, 120 mL bottle, Rx only, Distributed by: Bionpharma Inc., 600 Alexander Road,
Bionpharma recalls Clobazam oral suspension (2.5 mg/mL, 120mL) due to microbial contamination. This may cause health risks if used. Affected lots: 18246 (exp 09/2020).
BionpharmaJul 16, 2019
Bionpharma Inc. recall questions
How many recalls has Bionpharma Inc. had?
4 recalls from Bionpharma Inc. are on record with U.S. safety agencies, from 2019–2026.
What is the most recent Bionpharma Inc. recall?
Bionpharma Inc. recalls Doxylamine Succinate and Pyridoxine HCl Delayed-Release tablets 10 mg/10 mg, 100-count bottle, Rx Only, MADE IN INDIA,, dated Aug 7, 2026. Every Bionpharma Inc. recall is listed on this page, newest first.
Why are Bionpharma Inc. products recalled?
The most common reasons on record: Presence of Foreign Tablets/Capsules (2).
What should I do if I have a recalled Bionpharma Inc. product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new Bionpharma Inc. recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.